Business Context and Reporting Period
Company: Simmons First National Corporation (SFNC)
Filing Type: Form 8-K (Current Report)
Date of Report: July 21, 2025
Event: Pricing of an underwritten public offering of Class A common stock.
Key Financial Metrics
This filing reports a capital raising event rather than periodic financial performance. Specific metrics include:
- Shares Offered: 16,220,000 shares of Class A common stock.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 2,433,000 additional shares.
- Stock Par Value: $0.01 per share.
- Trading Symbol: SFNC (Nasdaq Global Select Market).
Note: The filing text does not provide a clear value for the offering price per share, total gross proceeds, revenue, profit, cash flow, margins, debt, or liquidity ratios.
Material Changes
The primary material change is the expansion of the company's equity capital base through the public offering described above. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
Use of Proceeds: Management indicated the offering is opportunistic and subject to market conditions. Proceeds are expected to be used for general corporate purposes, including potential repositioning of the Company's balance sheet.
Forward-Looking Statements: The filing contains forward-looking statements regarding future business operations, strategy, and the Offering. These are subject to risks and uncertainties that may cause actual results to differ materially.
Risks: Investors are directed to the "Risk factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, for a detailed discussion of risks.
Investor Verification Checklist
- Verify the final offering price per share and total gross proceeds in the accompanying Press Release (Exhibit 99.1).
- Confirm the specific allocation of proceeds for balance sheet repositioning.
- Review the Form 10-K filed on February 27, 2025, for detailed risk factors and prior financial condition.
- Monitor future filings to determine if the underwriters exercise the 30-day over-allotment option.